NCT05226559

Brief Summary

INTRODUCTION: It is very common that migraine patients could refer neck pain during or after the pain phase of migraine, suggesting that migraine pathophysiological mechanisms could be effective in activating neck pain pathways and be part of the migraine attack. Due to the therapeutic effect of multimodal physical therapy (mobilization and/or manipulation plus exercises) on several pain conditions arising from articular and/or muscular structures such as neck pain, and given the close clinical, anatomical and pathogenetic bi-directional relationship between neck pain and migraine, it would be of interest to evaluate the effectiveness of the physical treatment of the neck region in migraine pain. PURPOSE: to evaluate the efficacy of a combined multimodal physical therapy approach plus usual care vs. usual care alone in subjects with episodic and chronic migraine with concomitant cervical musculoskeletal dysfunctions. STUDY DESIGN: this is a prospective, parallel group, randomized clinical trial. METHODS: A total of 56 subjects aged 18-65 who meet criteria for episodic or chronic migraine with concomitant cervical musculoskeletal dysfunctions will be randomly assigned to receive, musculoskeletal focused multimodal physical therapy (16 sessions over 8 weeks) plus usual care treatment vs. usual care alone. CONFLICT OF INTEREST: not declared.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 7, 2022

Completed
17 days until next milestone

Study Start

First participant enrolled

February 24, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

2.8 years

First QC Date

January 11, 2022

Last Update Submit

February 27, 2024

Conditions

Keywords

Migraine;Chronic Migraine;Physical Therapy;Cervical musculoskeletal dysfunction;Joint Dysfunction;trigger point

Outcome Measures

Primary Outcomes (2)

  • Change in screening period monthly migraine days at the end of the intervention period (week 20) and at the end of the study (week 28) (daily migraine report)

    Number of monthly migraine days

    At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28)

  • Change in screening period monthly migraine days with use of acute medication at the end of the intervention period (week 20) and at the end of the study (week 28) (daily migraine report)

    Monthly migraine days with use of acute medication

    At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28)

Secondary Outcomes (3)

  • Change in screening period Migraine Disability Assessment Score (MIDAS) at the end of the intervention period (week 20) and at the end of the study (week 28)

    At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28)

  • Change in screening period Neck disability index (NDI) at the end of the intervention period (week 20) and at the end of the study (week 28)

    At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28)

  • Change in screening period Patient Health Questionnaire-9 (PHQ-9) at the end of the intervention period (week 20) and at the end of the study (week 28)

    At the end of the 12-week screening period (week 12), at the end of the 8-week intervention period (week 20), and at the end of the study 8 weeks after the last treatment (week 28)

Study Arms (2)

Multimodal Physical therapy approach plus usual care

ACTIVE COMPARATOR

HVLA spinal manipulation, mobilization, soft tissue treatment, therapeutic exercise, education, plus standard pharmacological treatment.

Procedure: Multimodal Physical therapy approach plus usual careDrug: Usual care

Usual care

NO INTERVENTION

Standard pharmacological treatment alone

Interventions

HVLA spinal manipulation, mobilization, soft tissue treatment, therapeutic exercise, education, plus standard pharmacological treatment.

Also known as: Intervention group
Multimodal Physical therapy approach plus usual care

Standard pharmacological treatment alone.

Also known as: Usual care group
Multimodal Physical therapy approach plus usual care

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged 18-65 years;
  • patients with episodic migraine with and without aura (experiencing 6-14 days/month with migraine);
  • patients with chronic migraine;
  • patients who achieved \>30% \<50% reduction from their individual baseline in the number of monthly migraine days on therapy with standard stable pharmacological treatments during the past 3 months;
  • concomitant cervical dysfunctions.

You may not qualify if:

  • self-report of neck injury/trauma;
  • acute radiculopathy;
  • history of carotid or vertebral artery dissection;
  • stroke;
  • cervical/cranial nerve block in the past three months;
  • pregnancy;
  • history of infection;
  • migraine attack during the assessment;
  • diagnosis of other concomitant headaches (such as cervicogenic headache, tension-type headache, cluster headache, medication overuse headache);
  • having received physical treatment in the past three months or botulinum toxin in the past six months;
  • any unstable medical o psychiatric condition.
  • history of any other rheumatic or chronic diseases such as fibromyalgia;
  • neuralgias, or self-report of vestibular disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Neuromed

Pozzilli, Isernia, 86077, Italy

RECRUITING

Related Publications (5)

  • Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.

    PMID: 29368949BACKGROUND
  • Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia. 2015 Mar;35(3):211-9. doi: 10.1177/0333102414535110. Epub 2014 May 22.

    PMID: 24853166BACKGROUND
  • Florencio LL, Chaves TC, Carvalho GF, Goncalves MC, Casimiro EC, Dach F, Bigal ME, Bevilaqua-Grossi D. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study. Headache. 2014 Jul-Aug;54(7):1203-10. doi: 10.1111/head.12393. Epub 2014 May 26.

    PMID: 24863346BACKGROUND
  • Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia. 2018 Apr;38(5):865-875. doi: 10.1177/0333102417716934. Epub 2017 Jun 22.

    PMID: 28641450BACKGROUND
  • Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep. 2003 Oct;7(5):371-6. doi: 10.1007/s11916-003-0036-y.

    PMID: 12946290BACKGROUND

MeSH Terms

Conditions

Migraine DisordersJoint Diseases

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMusculoskeletal Diseases

Study Officials

  • Armando Perrotta, MD

    Neuromed IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Armando Perrotta, MD

CONTACT

Luciano D'Ambrosio, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
Physiotherapists are blinded toward the diagnosis and outcome measures.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, parallel group, randomized clinical trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 11, 2022

First Posted

February 7, 2022

Study Start

February 24, 2022

Primary Completion

December 1, 2024

Study Completion

May 1, 2025

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations